Advertisement

In Vivo and in Vitro Infection of Human Langerhans Cells by HIV-1

  • Colette Dezutter-Dambuyant
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 378)

Abstract

The skin and mucosa are the first line of defense of the organism against external agents, not only as a physical barrier between the body and the environment but also as the site of initiation of immune reactions1. The immunocompetent cells which act as antigen-presenting cells are Langerhans cells (LC). Originated from the bone marrow, LC migrate to the peripheral epithelia (skin, mucous membranes) where they play a primordial role in the induction of an immune response and are especially active in stimulating naive T lymphocytes in the primary response through a specific cooperation with CD4-positive lymphocytes after migration to proximal lymph nodes2. Apart from many plasma membrane determinants, LC also express CD4 molecules which make them susceptible targets and reservoirs for human immunodeficiency virus type 1 (HIV-1)3. Once infected, these cells due to their localization in areas at risk (skin, mucous membranes), their capacity to migrate from the epidermal compartment to lymph nodes and their ability to support viral replication without major cytopathic effects, could play a role of vector in the dissemination of virus from the site of inoculation to the lymph nodes and thereby to contribute to the infection of T lymphocytes.

Keywords

Feline Immunodeficiency Virus Birbeck Granule Feline Immunodeficiency Virus Infection Mucosal Transmission Epidermal Compartment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. de Fraissinette, D. Schmitt, and J. Thivolet, Ontogeny of Langerhans cells : phenotypic differentiation from the bone marrow to the skin, Dev. Comp. Immunol. 14:335 (1990).PubMedCrossRefGoogle Scholar
  2. 2.
    C. Dezutter-Dambuyant, Cultures of Langerhans cells and co-culture with lymphoid cells : relevance to toxicology and pharmacology, Toxic, in Vitro 5:585 (1991).CrossRefGoogle Scholar
  3. 3.
    M.B.M. Teunissen, Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review with emphasis on human Langerhans cells, Histochemical J. 24:697 (1992).CrossRefGoogle Scholar
  4. 4.
    D.V. Belsito, M.R. Sanchez, R.L. Baer, F. Valentine and G. Thorbecke, Reduced Langerhans‘cell la antigen and ATPase activity in patients with the acquired immunodeficiency syndrome, N. Engl. J. Med. 310:1279 (1984).PubMedCrossRefGoogle Scholar
  5. 5.
    K. Rappersberger, S. Gartner, P. Schenk, G. Stingl, V. Groh, E. Tschachler, D. Mann, K. Wolff, K. Konrad and M. Popovic, Langerhans‘cells are an actual site of HIV-1 replication, Intervirology 29:185(1988).PubMedGoogle Scholar
  6. 6.
    E. Tschachler, V. Groh, M. Popovic, D. Mann, K. Konrad, B. Safai, L. Eron, F. Veronese, K. Wolff and G. Stingl, Epidermal Langerhans cells -A target for HTLV-IIIB/LAV infection, J. Invest. Dermatol. 88:233 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    V. Gielen, D. Schmitt, C. Dezutter-Dambuyant and J. Thivolet, AIDS and Langerhans cells : CD4 antigenic site density modification evidenced by single-cell immunogold labeling, Reg. Immunol. 2:7 (1989).PubMedGoogle Scholar
  8. 8.
    J.D. Money, S.M. Bourn, T.D. Bunch, M.K. Jackson, R.W. Sidwell, L.R. Barrows, R.A. Daynes and C.A. Rosen, In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type-A (UV-A) light plus psoralen and UV-B light in skin of transgenic mice, J. Virol. 65:5045 (1991).Google Scholar
  9. 9.
    J. Vogel, M. Cepeda, E. Tschachler, L.A. Napolitano and G. Jay, UV activation of human immunodeficiency virus gene expression in transgenic mice, J. Virol. 66:1 (1992).PubMedGoogle Scholar
  10. 10.
    J.D. Morrey, M.K. Jackson, T.D. Bunch and R.W. Sidwell, Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice, Intervirology 36:65 (1993).PubMedGoogle Scholar
  11. 11.
    H. Naher, T. Schule and D. Petzoldt, Evidence for genetic HIV variants from detection of HIV-DNA, Lancet 338:519 (1991).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Kanitakis, S. Escaich, C. Trepo and J. Thivolet, Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction, J. Invest. Dermatol. 97:91 (1991)PubMedCrossRefGoogle Scholar
  13. 13.
    G. Zambruno, L. Mori, A. Marconi, N. Mongiardi, B. De Rienzo, U. Bertazzoni and A. Gianetti, Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction, J. Invest. Dermatol. 96:979 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    D.C. Kalter, J.J. Greenhouse, J.M. Orenstein, S.M. Schnittman, H.E. Gendelman and M.S. Meltzer,Epidermal Langerhans cells are not principal reservoirs of virus in HIV disease, J. Immunol. 146:3396 (1991).PubMedGoogle Scholar
  15. 15.
    N. Dusserre, C. Dezutter-Dambuyant, F. Mallet, P. Delorme, F. Philit, A. Ebersold, C. Desgranges, J. Thivolet and D. Schmitt, The in vitro HIV-1 entry and replication in Langerhans cells may clarify the HIV-1 genome detection by PCR in epidermis of seropositive patients, J. Invest. Dermatol. 99:99 (1992).CrossRefGoogle Scholar
  16. 16.
    A. Gianetti, G. Zambruno, A. Cimarelli, A. Marconi, M. Negroni, G. Girolomoni and U. Bertazzoni, Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients, J. Acq. Immune Def. Synd. 6:329 (1993).Google Scholar
  17. 17.
    A. Cimarelli, G. Zambruno, A. Marconi, G. Girolomoni, U. Bertazzoni and A. Giannetti,Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients, J. Acq. Immune Def. Synd. 7:230 (1994).Google Scholar
  18. 18.
    C. Dezutter-Dambuyant, D.A. Schmitt, N. Dusserre, D. Hanau, H.V.J. Kolbe, M.P. Kieny, J.P. Cazenave, D. Schmitt, J.L. Pasquali, R. Olivier, L. Gazzolo, and J. Thivolet, Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope, J. Dermatol. 18:377 (1991).PubMedGoogle Scholar
  19. 19.
    C. Dezutter-Dambuyant, D.A. Schmitt, N. Dusserre, D. Hanau, H.V.J. Kolbe, M.P. Kieny, L. Gazzolo, K. Macé J.L. Pasquali, R. Olivier and D. Schmitt, Trypsin-resistant gp 120 receptors are upregulated on short-term cultured human epidermal Langerhans cells, Res. Virol. 142:129 (1991).PubMedCrossRefGoogle Scholar
  20. 20.
    N. Dusserre, P. Delorme, C. Dezutter-Dambuyant, A. Ebersold, M. Trabot, C. Desgranges and D.Schmitt, In vitro transmission of human immunodeficiency virus type-1 from monocytes to epidermal Langerhans cells results in virion entry through receptor-mediated endocytosis, Europ. J. Dermatol. 1:139 (1991).Google Scholar
  21. 21.
    P. Delorme, C. Dezutter-Dambuyant, A. Ebersold, C. Desgranges, J. Thivolet and D. Schmitt, In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate, Res. Virol. 144:53 (1993).PubMedCrossRefGoogle Scholar
  22. 22.
    A.S. Charbonnier, F. Mallet, MM. Fiers, C. Desgranges, C. Dezutter-Dambuyant and D. Schmitt, Detection of HIV-specific DNA sequences in epidermal Langerhans cells infected in vitro by means of a cell free system, Arch. Dermatol. Res. in press (1994).Google Scholar
  23. 23.
    N.C. Pedersen, E.W. Ho, M.L. Brown and J.K. Yamamoto, Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome, Science 235:790 (1987).PubMedCrossRefGoogle Scholar
  24. 24.
    J.K. Yamamoto, E. Sparger, E.W. Ho, P.R. Andersen, T.P. O’Connor, C.P. Mandell, L.N. Lowenstine, R. Munn and N.C. Pedersen, Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats, Am. J. Vet. Res. 49:1246 (1988).PubMedGoogle Scholar
  25. 25.
    T.R. Moench, K.J. Whaley, T.D. Mandrell, B.D. Bishop, C.J. Witt and R.A. Cone, The cat/FIV model for transmucosal transmission of AIDS : nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum, AIDS 7:797 (1993).PubMedCrossRefGoogle Scholar
  26. 26.
    C. Tsagarakis, T. Marchal, J.P. Magnol, C. Fournel, C. Dezutter-Dambuyant and D. Schmitt, Contribution of the feline Langerhans cell in the FIV model, Res. Virol. 145:000 (1994).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Colette Dezutter-Dambuyant
    • 1
  1. 1.INSERM U 346, Peau Humaine et Immunité (Directeur: Daniel Schmitt)Hôpital Edouard HerriotLyonFrance

Personalised recommendations